Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001929354-23-000002

10% owner bought 56,329 shares at an average $2.53 ($142,516)

From the SEC's structured data for this filing

Trades in this filing

Caissa Capital Management ltd. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-10 Purchase : show line 1 in the form +31,329 $2.28 $71,436 1,242,700 I
2023-04-11 Purchase : show line 2 in the form +25,000 $2.84 $71,080 1,267,700 I
Open-market purchases · 56,329 sh · avg $2.53 · $142,516
Loading xslF345X04/primary_doc.xml…